Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Medicare Drug Card Auto-Enrollment? CMS Cites Problems, But Democrats Urge Approval

This article was originally published in The Pink Sheet Daily

Executive Summary

Twenty-six House and Senate Democrats make new push for automatic Medicare Rx card enrollment of low-income seniors; Sen. Conrad calls on HHS to pare down list of card sponsors.

You may also be interested in...



CMS Will Auto-Enroll 1.8 Mil. Low-Income Seniors For Medicare Rx Cards

The agency will randomly assign all Medicare Savings Program beneficiaries into one of 19 participating national cards. The addition of 1.8 mil. beneficiaries brings the total number of card program enrollees up 41% to 6.2 mil.

CMS Will Auto-Enroll 1.8 Mil. Low-Income Seniors For Medicare Rx Cards

The agency will randomly assign all Medicare Savings Program beneficiaries into one of 19 participating national cards. The addition of 1.8 mil. beneficiaries brings the total number of card program enrollees up 41% to 6.2 mil.

Medicare Low-Income Transition Commission To Hold Public Meeting July 7

The 25-member commission will discuss issues related to ensuring a smooth transition for low-income beneficiaries from state pharmaceutical assistance programs into Medicare Part D in 2006.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS059910

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel